Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies

Leukemia

Volumn 10, Issue 5, 1996, Pages 877-895

  Rothe, G ^a   Schmitz, G ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Consensus protocol; Flow cytometry; Leukemia; Lymphoma

Indexed keywords

ARTICLE; CANCER CYTODIAGNOSIS; FLOW CYTOMETRY; GOOD LABORATORY PRACTICE; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; QUALITY CONTROL; STANDARDIZATION;

EID: 0029934173     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401612     Document Type: Article

References (49)

1. Argyle JC, Benjamin DR, Lampkin B, Hammond D. Acute nonlymphocytic leukemias in childhood: Inter-observer variability and problems in the use of the FAB classification. Cancer 1989; 63: 295-301.
2. Bene MC, Castoldi C, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB. Proposals for the immunological classification of acute leukemias. Leukemia 1995; 9: 1783-1786.
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. The French-American-British (FAB) Cooperative Group, Proposals for the classification of chronic (mature) B and T lymphoid leukaemia. J Clin Pathol 1989; 42: 567-584.
4. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7). Ann Intern Med 1985; 103: 460-462.
5. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985; 103: 626-629.
6. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol 1991; 78: 325-329.
7. Buccheri V, Matutes E, Dyer MJ, Catovsky D. Lineage commitment in biphenotypic acute leukemia. Leukemia 1993; 7: 919-927.
8. Buccheri V, Mihaljevic B, Matutes E, Dyer MJ, Mason DY, Catovsky D. mb-1 : a new marker for B-lineage lymphoblastic leukemia. Blood 1993; 82: 853-857.
9. Calvelli TA, Denny TN, Paxton H, Gelman R, Kagan J. Guideline for the flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, division of AIDS. Cytometry 1993; 14: 702-714.
10. Campana D, Coustan-Smith E, Janossy G. The immunologic detection of minimal residual disease in acute leukemia. Blood 1990: 76: 163-171.
11. Carter PH, Resto-Ruiz S, Washington GC, Ethridge S, Pallini A, Vogt R, Waxdal M, Fleisher T, Noguchi PD, Marti GE. Flow cytometric analysis of whole blood lysis, three anticoagulants, and five cell preparations. Cytometry 1992; 13: 68-74.
12. Castoldi GL, Liso V, Fenu S, Vegna ML, Mandelli F. Reproducibility of the morphological diagnostic criteria of acute myeloid leukemia: the GIMEMA group experience. Ann Hematol 1993; 66: 171-174.
13. Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, Brunning R, Gale RP, Grever MR, Keating MJ et al. Report of the National Cancer Institute-sponsored Workshop on Definitions of Diagnosis and Response in Acute Myeloid Leukemia. J Clin Oncol 1990; 8: 813-819.
14. Creutzig U, Harbott J, Sperling C, Ritter J, Zimmermann M, Löffler H, Riehm H, Schellong G, Ludwig WD. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87. Blood 1995; 86: 3097-3108.
15. Drexler HG, Sperling C, Ludwig WG. Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia. Leukemia 1993; 7: 1142-1150.
16. Drexler HG, Thiel E, Ludwig WD. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 1991; 5: 637-645.
17. Drexler HG, Thiel E, Ludwig WD. Acute mveloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. Leukemia 1993; 7: 489-498.
18. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Clearry ML, Delsol G, De Wolf Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lyrnphoma Study Group. Blood 1994; 84: 1361-1392.
19. Knapp W, Majdic O, Strobl H. Flow cytometric analysis of intracellular myeloperoxidase and lactoferrin in leukemia diagnosis. In: Ludwig WD, Thiel E (eds). Recent Advances in Cell Biology of Acute Leukemia: Impact on Clinical Diagnosis and Therapy (Recent Results in Cancer Research, vol. 131). Springer Verlag: Berlin, Heidelberg, 1993, pp 31-40.
20. Lewis DE, Rickman WJ. Methodology and quality control for flow cytometry. In: Rose NR, de Macario EC, Fahey JL, Friedman H, Penn GM (eds). Manual of Clinical Laboratory Immunology, 4th edn American Society for Microbiology: Washington DC, 1991, pp 117-141.
21. Loken MR, Brosnan JM, Bach BA, Ault KA. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytomeirv 1990; 11: 453-459.
22. Loken MR, Grenier KA, Bach BA. A selected 12-reagent immunophenotyping panel facilitates assignment of lineage in acute leukemia. Clinical Monograph No. 3, Becton Dickinson Immunocytometry Systems, 1992, pp1-28.
23. Ludwig WD, Komischke B, Böttcher S. Immunphänotypisierung akuter Leukämien und leukämisch verlaufender niedrig-maligner Non-Hodgkin-Lymphome (Methoden, relevante, Antigene, Interpretation). In: Schmitz C, Rothe G (eds). Durchfluβzytometrie in der klinischen Zelldiagnostik. Schattauer: Stuttgart, 1994, pp 77-104.
24. Ludwig WD, Raghavachar A, Thiel E. Immunophenotypic classification of acute lymphoblastic leukaemia. Baillière's Clin Haematol 1994; 7: 235-262.
25. Ludwig WD, Reiter A, Löffler H, Gökbuget, Hoelzer D, Riehm H, Thiel E. Immunophenotypic features of childhood and adult acute lymphoblastic leukemia (ALL): experience of the German multicentre trials ALL-BFM and GMALL. Leuk Lymphoma 1994; 13 (Suppl. 1): 71-76.
26. Ludwig WD, Thiel E. Diagnostik der akuten Leukämien mit morphologischen, immunologischen und zytogenetischen Verfahren. Internist 1993; 34: 498-510.
27. Matutes E, Owusu-Ankomah K, Morilla R, Marco JG, Houlihan A, Que TH, Catovsky D. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640-1645.
28. McCoy JP, Carey JL, Krause JR. Quality control in flow cytometry for diagnostic pathology. I. Cell surface phenotyping and general laboratory procedures. Am J Clin Pathol 1990; 93 (Suppl. 1): S27-S37.
29. National Committee for Clinical Laboratory Standards. Clinical applications of flow cytometry: quality assurance and immunophenotyping of peripheral blood lymphocytes; tentative guideline. NCCLS document H42-T (ISBN 1-56238-155-5). NCCLS, Villanova, PA, 1992.
30. National Committee for Clinical Laboratory Standards. Clinical applications of flow cytometry: Immunophenotyping of leukemic cells; proposed guideline. NCCLS document H43-P (ISBN 1-56238-219-5). NCCLS, Villanova, PA, 1993.
31. Pinto A, Gattei V, Soligio D, Parravicini C, Del Vecchio L. New molecules at the leukocyte surface: a comprehensive review based on the 5th International Workshop on Leukocyte Differentiation Antigens, Boston, USA, 3-7 November, 1993. Leukemia 1994; 8: 347-358.
32. Pizzolo G, Vincenzi C, Nadali G, Veneri D, Vinante F, Chilosis M, Basso G, Connelly MC, Janossy G. Detection of membrane and intracellular antigens by flow cytometry following ORTHO Perme-aFix fixation. Leukemia 1994; 8: 672-676.
33. Pui CH, Behm FG, Crist WM. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 1993; 82: 343-362.
34. Ryan DH. Phenotypic heterogeneity in acute leukemia. Clin Chim Acta 1992; 206: 9-23.
35. Schlossmann SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein RL, Springer TA, Tedder TF, Todd RF (eds). Leukocyte Typing V: White Cell Differentiation Antigens. Oxford University Press: London, Oxford, 1995.
36. Terstappen LWMM, Safford M, Könemann S, Loken MR, Zurlutter K, Büchner Th, Hiddemann W, Wörmann B. Flow cytometric characterization of acute myeloid leukemia. II. Phenotypic heterogeneity at diagnosis. Leukemia 1992; 6: 70-80.
37. Terstappen LWMM, Könemann S, Safford M, Loken MR, Zurlutter K, Büchner Th, Hiddemann W, Wörmann B. Flow cytometric characterization of acute myeloid leukemia. I. Light scattering. Leukemia 1991; 5: 315-321.
38. Terstappen LWMM, Safford M, Unterhalt M, Könemann S, Zurlutter K, Piechotka K, Drescher M, Aul C, Büchner Th, Hiddemann W, Wörmann B. Flow cytometric characterization of acute myeloid leukemia. IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cells. Leukemia 1992; 6: 993-1000.
39. Traweek ST. Immunophenotypic analysis of acute leukemia. Am J Clin Pathol 1993; 99: 504-512.
40. Urbano-Ispizua A, Matutes E, Villamor N, Sierra J, Pujades A, Reverter JC, Feliu E, Cervantes F, Vives-Corrons JL, Montserrat E et al. The value of detecting surface and cytoplasmic antigens in acute myeloid leukemia. Br J Haematol 1992; 81: 178-183.
41. van der Does-van den Berg A, Bartram CR, Basso G, Benoit YCM, Biondi A, Debatin KM, Haas OA, Harbott J, Kamps WA, Köller U, Lampert F, Ludwig WD, Niemeyer CM, van Wering ER. Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphblastic leukemia (ALL) in the 'BFM Family' cooperative group. Med Pediat Oncol 1992; 20: 497-505.
42. van't Veer MB. The diagnosis of acute leukemia with undifferentiated or minimally differentiated blasts. Ann Hematol 1992;64: 161-165.
43. van't Veer MB, Kluin-Nelemans JC, van der School E, van Putten WLJ, Adriaansen HJ, Wering ER. Quality assessment of immunological marker analysis in the diagnosis of leukemia and lymphoma: a multicenter study. Br J Haematol 1992; 10: 450-465.
44. van Dongen JJM, Breit TM, Adriaansen HJ, Beishuizen A, Hooijkas H. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia 1992; 6: 47-59.
45. Verschuren MC, Comans-Bitter WM, Kapteijn CA, Mason DY, Brouns CS, Borst J, Drexler HC, van Dongen JJM. Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines. Leukemia 1993; 7: 1939-1947.
46. Verwer BJ, Terstappen LWMM. Automatic lineage assignment of acute leukemias by flow cytometry. Cytometry 1993; 14: 862-875.
47. Vidriales MB, Orfao A, Lopez-Berges MC, Gonzalez M, López-Macedo A, Garcia MA, Galende J, San Miguel JF. Light scatter characteristics of blast cells in acute myeloid leukaemia: association with morphology and immunophenotype. J Clin Pathol 1995; 48: 456-462.
48. Wörmann B, Grove D, Terstappen LWMM. Multiparametrische Charakterisierung von Leukämie und Lymphomzellen. In: Schmitz G, Rothe G (eds). Durchfluβzytometrie in der klinischen Zelldiagnostik. Schattauer: Stuttgart, 1994, pp 105-115.
49. Wörmann B, Safford M, Könemann S, Büchner Th, Hiddemann W, Terstappen LWMM. Detection of aberrant antigen expression in acute myeloid leukemia by multiparameter flow cytometry. Recent Results Cancer Res 1993; 131: 185-196.